Study: Glaxo’s Tykerb Reduces Breast Cancer-Causing Stem Cells

GlaxoSmithKline Plc. said a new study into breast cancer-causing stem cells showed its cancer drug...

» read full story

April 17th, 2008 - 16:17

Glaxo Gets Positive EMEA Opinion on Its Cancer Drug Tykerb

The world’s second-biggest drugmaker, GlaxoSmithKline PLC said Friday that the European Medicines...

» read full story

December 17th, 2007 - 14:54

GlaxoSmithKline's Tykerb Marketed in EU as Tyverb

The European Medicines Agency (EMEA) has granted GlaxoSmithKline conditional approval to sell their...

» read full story

December 14th, 2007 - 20:32

Update: FDA Reveals List Of Drugs Posing Health Risks

The US Food and Drug Administration is planning to raise awareness on possible side effects of...

» read full story

September 08th, 2008 - 14:00